Results 1 to 10 of about 491,575 (216)

Anesthetic implications in hyperthermic intraperitoneal chemotherapy

Journal of Anaesthesiology Clinical Pharmacology, 2019
Patients with peritoneal carcinomatosis were considered incurable with dismal survival rates till hyperthermic intraperitoneal chemotherapy after optimal cytoreductive surgery evolved. Perioperative management for these procedures is complex and involves
Nishkarsh Gupta, Vinod Kumar, Rakesh Garg, Sachidanand Jee Bharti, Seema Mishra, Sushma Bhatnagar   +5 more
doaj   +4 more sources

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer [PDF]

Diagnostics, 2020
Hyperthermic intraperitoneal chemotherapy (HIPEC) in conjunction with cytoreductive surgery (CRS) holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual ...
McKayla J. Riggs, Prakash K. Pandalai, Joseph Kim, Charles S. Dietrich   +3 more
doaj   +4 more sources

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case report

Saudi Journal of Anaesthesia, 2023
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly influence overall and disease-free survival in selected patients suffering from peritoneal surface malignancies (PSMs).
Nilanjana Howbora, Swaraj J Sonowal, Tridip J Borah, Sonai D Kakati, Anupam Das, Marie Ninu, Dokne Chintey   +6 more
doaj   +2 more sources

Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial

International Journal of Hyperthermia, 2023
Objective To compare the efficacy and safety of hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy in the treatment of malignant pleural or peritoneal effusion.Methods A randomized ...
Lili Liu, Tao Zhang, Xiang Song, Cheng-gong Liao, Tengyun Xu, Yang Yang, Ming Zeng, Junmei Jia, Haichuan Su, Yang Song, Jie Min, Hongmei Zhang, Wei Li, Hongwei Zhang, Helong Zhang   +14 more
doaj   +2 more sources

Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review

Current Oncology, 2023
Desmoplastic small round cell tumor is a very rare and highly aggressive soft tissue sarcoma, usually presenting with multiple intra-abdominal tumors in young males. Patients present with advanced disease and the overall survival is dismal.
Sophie J. M. Reijers, Caroline C. H. Siew, Niels F. M. Kok, Charles Honoré, Winan J. van Houdt   +4 more
doaj   +2 more sources

Perioperative anaesthetic management in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a retrospective analysis in a single tertiary care cancer centre

Pleura and Peritoneum, 2022
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is associated with increased morbidity and mortality. We retrospectively analysed the perioperative anesthetic management in patients undergoing HIPEC surgery.
Gupta Raghav, Gupta Nishkarsh, Sirohiya Prashant, Pandit Anuja, Ratre Brajesh Kumar, Vig Saurabh, Bhan Swati, Singh Ram, Kumar Balbir, Bhopale Shweta, Mishra Seema, Garg Rakesh, Bharati Sachidanand Jee, Kumar Vinod, Deo Suryanarayana, Bhatnagar Sushma   +15 more
doaj   +2 more sources

Hyperthermic intraperitoneal chemotherapy: Ideal and reality

Asian Journal of Surgery
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is a new adjuvant therapy for the treatment of abdominal malignant tumors and metastases, which has shown great potential.
Fan-He Dong, Yu-Qiang Shan, Wen-Cheng Kong, Hao-Ran Wei, Lin-Po Zhou, Ye-Bin Yang, Jing Shi, Cheng-Hao Ji, Yi-Jia Zhang   +8 more
doaj   +3 more sources

Hyperthermic intraperitoneal chemotherapy in ovarian cancer: an update

Hormone Molecular Biology and Clinical Investigation, 2020
Abstract In the treatment of advanced-stage epithelial ovarian cancer (EOC)-associated surgery and chemotherapy with intravenous platinum/taxane-based therapy most patients had early or late recurrence. Prevention of progression and recurrence is a major objective for the management of EOC.
Revaux, A., Carbonnel, M., Kanso, F., Naoura, I., Asmar, J., Kadhel, P., Ayoubi, J.-M.   +6 more
openaire   +4 more sources

Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge

Indian Journal of Anaesthesia, 2014
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy plays a considerable role as a treatment modality in surgical oncology in western countries. The advantage of this procedure is that the heated chemotherapeutic agent is circulated in the abdominal cavity and achieves high peritoneal concentration with limited systemic ...
Kavita Murughan, Malati Tiwari, Kalpana Balakrishnan   +2 more
openaire   +4 more sources

The Registry of Hyperthermic Intraperitoneal Chemotherapy – A Mandatory Step in the Development of this Therapeutic Approach in Romania

Applied Medical Informatics, 2015
Multicenter/institutional studies have been the basis for the confirmation of Hyperthermic Intraperitoneal Chemotherapy as a therapeutic option for selected patients with Peritoneal Surface Malignancies.
Corneliu LUNGOCI, Tudor CĂLINICI, Olga ORĂŞAN, Rareş BOSU, Valentin MUNTEAN, Aurel Ion MIRONIUC   +5 more
doaj   +1 more source